Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 61 citing articles:

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4232
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
Péter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 159-216
Open Access | Times Cited: 87
Glucagon-like Peptide 1 Receptor Agonists and Cardiovascular Outcomes in Solid Organ Transplant Recipients With Diabetes Mellitus
I Dotan, Yaron Rudman, ‪Adi Turjeman‬‏, et al.
Transplantation (2024)
Closed Access | Times Cited: 9
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
Roko Škrabić, Marko Kumrić, Josip Vrdoljak, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 37
Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease
Daniel E. Forman, George A. Kuchel, John C. Newman, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 7, pp. 631-647
Open Access | Times Cited: 20
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiovascular Risk Management in Patients With Type 2 Diabetes Mellitus: A Systematic Review
Panah Parab, Priti Chaudhary, Sonia Mukhtar, et al.
Cureus (2023)
Open Access | Times Cited: 20
Diabetes mellitus treatment
Chin Meng Khoo
Elsevier eBooks (2023), pp. 417-427
Closed Access | Times Cited: 17
Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials
Liyun He, Jialu Wang, Fan Ping, et al.
BMJ (2022), pp. e068882-e068882
Open Access | Times Cited: 27
The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture
Bingzi Dong, Ruolin Lv, Jun Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 24
Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
Jinjing Wei, Bin Yang, Ruxin Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway
Xinyue Li, Bu-tuo Xu, Jing Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 19
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies
André Scheen
Diabetes & Metabolism (2023) Vol. 49, Iss. 5, pp. 101474-101474
Closed Access | Times Cited: 11
Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)
Lin Zhang, Wei Mao, Dan Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Cardiovascular Safety Profile of Semaglutide and Variations by Sex, Race, and Kidney Function: A Systematic Review and Meta-analysis
Muhammad Hamayal, Chaudhary Humayun Akhtar, Naveed Ahmad, et al.
American Journal of Cardiovascular Drugs (2025)
Closed Access
Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review
M. Belhadj, Rachid Malek, Houssem Baghous, et al.
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 6
Open Access
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
Xiayun Ni, Lei Zhang, Xiaojun Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia
Juan M. Munoz Pena, Kenneth Cusi
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. e1-e11
Open Access | Times Cited: 10
Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis
C. Li, Yue Hu, Zengyi Mu, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 3
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database
Takanori Imai, Naoto Kato, Naoki Kanda, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 8, pp. 1821-1830
Open Access | Times Cited: 3
Incretin mimetics and acute pancreatitis: enemy or innocent bystander?
Richard E. Pratley, Zeb Saeed, Anna Casu
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 5, pp. 404-412
Closed Access | Times Cited: 3
Hypothesizing glucagon-like peptide 1 (GLP-1), agonists promote hypodopaminergia, resulting in heightened addictive reward-seeking and altered mood: Breaking the bubble and adding salt to a wound
Kenneth Blum, Catherine A. Dennen, Kai-Uwe Lewandrowski, et al.
Medical Hypotheses (2025), pp. 111612-111612
Closed Access
O Uso de Inibidores do Cotransportador Sódio-Glicose 2 (ISGLT2) nos Pacientes com Fração de Ejeção Reduzida: Uma Revisão Integrativa
Irving Gabriel Araújo Bispo, Guilherme Martins Chaves, Mariana Gonçalves Fernandes, et al.
ABC Heart Failure & Cardiomyopathy (2025) Vol. 5, Iss. 1
Open Access
Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study
Omar Dzaye, Philipp Berning, Alexander C. Razavi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Evaluation of the Effect of Sodium-Glucose Cotransporter 2 Inhibition on Fracture Risk: Evidence From Mendelian Randomization and Genetic Association Study
Huajie Dai, Longyi Zheng, Zheng Zhu, et al.
Journal of Bone and Mineral Research (2023) Vol. 38, Iss. 11, pp. 1645-1653
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top